Jefferies Financial Group’s Neuronetics STIM Stock Holding History

Jefferies Financial Group’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$176K	Buy	+75,000	New	+$184K	﹤0.01%	1144

Other funds holding STIM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Jefferies Financial Group's STIM Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Neuronetics (STIM) in Q3 2026: 75,000 shares worth $176K. The stake represents ﹤0.01% of the portfolio and ranks #1144 among its holdings.

21 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

Jefferies Financial Group held 75,000 shares of Neuronetics worth $176K as of Q3 2026.
Neuronetics was a new Jefferies Financial Group position in Q3 2026.
Neuronetics made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1144 holding.
21 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.